Thyroid hormone antagonists: potential medical applications and structure activity relationships

Area of Science:

• Endocrinology and Molecular Pharmacology

Background:

• Thyroid hormones (3,5,3'-triiodo-L-thyronine [L-T(3)] and 3,5,3',5'-tetraiodo-L-thyronine [L-T(4)]) are critical regulators of metabolism, development, and organ function.
• Thyrotoxicosis, resulting from elevated thyroid hormone levels, manifests with symptoms like weight loss, heat intolerance, cardiac issues, and neuropsychiatric disturbances.
• Current treatments for hyperthyroidism involve inhibiting hormone synthesis, release, or ablating thyroid tissue.

Purpose of the Study:

• To explore the potential of thyroid hormone receptor (TR) antagonists in treating thyrotoxic states.
• To review strategies for designing TR antagonists, particularly TRalpha-selective ligands for cardiac conditions.

Main Methods:

• Review of synthetic TR antagonist designs, focusing on strategies involving extensions at the 5-prime position of L-T(3) analogues.
• Analysis of how these extensions are hypothesized to disrupt TR ligand binding domain (LBD) function by affecting helix 12 interactions.
• Exploration of alternative approaches to achieve functional TR antagonism.

Main Results:

• TR antagonists hold theoretical promise for rapidly normalizing thyroid-specific gene activity in thyrotoxicosis.
• No TRalpha-selective ligands have been developed, limiting therapeutic options for hyperthyroidism-associated cardiac issues.
• Ligand design strategies, primarily based on bulky extensions, aim to distort TR LBD conformation and inhibit coactivator binding.

Conclusions:

• TR antagonists represent a potential therapeutic avenue for thyrotoxicosis, offering a different mechanism than current treatments.
• Further research into TR antagonist design, especially TRalpha-selective compounds, is needed to address clinical limitations.
• The development of effective TR antagonists could offer a valuable alternative for managing hyperthyroid conditions.